Martin Pichler
Has participated in:
-
Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients
-
Circulating non-coding RNAs in renal cell carcinoma—pathogenesis and potential implications as clinical biomarkers
-
Current concepts of non-coding RNAs in the pathogenesis of non-clear cell renal cell carcinoma
-
MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer